@MTomasson Yes, there is single agent activity of inobrodib not only in Vk*MYC myeloma, but also in humans with myeloma.

CellCentric announces $25m strategic investment from Pfizer

This explains the neutropenia seen in myeloma patients treated with therapies targeting normal plasma cells. Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow. Immunity 2019

y RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease L

RT @NBahlis: Daratumumab Vennetoclax Dexamethasone is the answer for t(11;14) myeloma.

Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.

Off label use of Thalidomide and Lenalidomide has helped thousands of myeloma patients despite whistleblower claims

How does Revlimid work in #myeloma? This article in @NatureMedicine shows it blocks the lactate exporter.

National Cancer Institute Awards SPORE grant to multiple myeloma research team from Mayo Clinic Cancer Center http://t.co/mKK2Ii77P5

Check out the following survey on Revlimid maintenance: http://t.co/2mweBBQX

@jaybradner Amazing talk about open source cancer treatment Jay! http://t.co/fqX0d0nE

@JonathanKeats you'll thank me one day...